busulfan has been researched along with Chronic Kidney Failure in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with multiple myeloma (MM) and chronic renal failure have generally been excluded from myeloablative therapy programs followed by hematopoietic stem cell support because of the potential increase in transplant-related morbidity and mortality." | 1.31 | Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. ( Benni, M; Cavo, M; Motta, MR; Rizzi, S; Ronconi, S; Tosi, P; Tura, S; Zamagni, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, K | 1 |
| Ashizawa, M | 1 |
| Toda, Y | 1 |
| Ikeda, T | 1 |
| Kawaguchi, SI | 1 |
| Ito, S | 1 |
| Ochi, SI | 1 |
| Nagayama, T | 1 |
| Mashima, K | 1 |
| Umino, K | 1 |
| Minakata, D | 1 |
| Nakano, H | 1 |
| Yamasaki, R | 1 |
| Yamamoto, C | 1 |
| Hatano, K | 1 |
| Fujiwara, SI | 1 |
| Sato, K | 1 |
| Oh, I | 1 |
| Ohmine, K | 1 |
| Muroi, K | 1 |
| Matsumoto, K | 1 |
| Kanda, Y | 1 |
| Ullery, LL | 1 |
| Gibbs, JP | 1 |
| Ames, GW | 1 |
| Senecal, FM | 1 |
| Slattery, JT | 1 |
| Tosi, P | 1 |
| Zamagni, E | 1 |
| Ronconi, S | 1 |
| Benni, M | 1 |
| Motta, MR | 1 |
| Rizzi, S | 1 |
| Tura, S | 1 |
| Cavo, M | 1 |
3 other studies available for busulfan and Chronic Kidney Failure
| Article | Year |
|---|---|
Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease.
Topics: Busulfan; Humans; Kidney Failure, Chronic; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Renal | 2020 |
Busulfan clearance in renal failure and hemodialysis.
Topics: Administration, Oral; Biological Availability; Blood Transfusion, Autologous; Busulfan; Hematopoieti | 2000 |
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; | 2000 |